Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of BIIB033 in Subjects With Multiple Sclerosis

This study has been completed.
Information provided by (Responsible Party):
Biogen Identifier:
First received: November 18, 2010
Last updated: November 8, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):